# A Phase 1 Study of Mosliciguat in Healthy, Adult Males

> **NCT07185321** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Pulmovant, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Mosliciguat
- **DRUG:** 14C mosliciguat
- **DEVICE:** Dry Powder Inhaler

## Key facts

- **NCT ID:** NCT07185321
- **Lead sponsor:** Pulmovant, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2026-03
- **Final completion:** 2026-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07185321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07185321, "A Phase 1 Study of Mosliciguat in Healthy, Adult Males". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07185321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*